Immutep (IMMP) Cash from Financing Activities (2016 - 2017)
Immutep's (IMMP) quarterly Cash from Financing Activities came in at -$1603.1 in Q2 2017, down 100.8% YoY from $200118.5 in Q2 2016, and down 100.8% on a QoQ basis from $200118.5 in Q2 2016.
Immutep (IMMP) Cash from Financing Activities (2016 - 2017) Analysis & Trends
Immutep (IMMP) has 2 years of Cash from Financing Activities data on file, last reported at -$1603.1 in Q2 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -426.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -1.22 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 14.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | -6.05 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 36.24 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -16.65 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 27.18 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -273.15 Mn |
| 10 | Immutep | 56.46 Mn | -8.63 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2017 | -1,603.08 |
| Jun 30, 2017 | -1,603.08 |
| Jun 30, 2016 | 200,118.49 |
| Jun 30, 2016 | 200,118.49 |